Clinical and Translational Discovery (Sep 2022)

Interferon signalling contributes to therapy‐resistant prostate cancer progression

Amanda W. Dong,
Artem Cherkasov,
Xuesen Dong

Affiliations

Amanda W. Dong: Department of Urologic Sciences, The Vancouver Prostate Centre, Faculty of Medicine The University of British Columbia Vancouver Canada
Artem Cherkasov: Department of Urologic Sciences, The Vancouver Prostate Centre, Faculty of Medicine The University of British Columbia Vancouver Canada
Xuesen Dong: Department of Urologic Sciences, The Vancouver Prostate Centre, Faculty of Medicine The University of British Columbia Vancouver Canada

DOI: https://doi.org/10.1002/ctd2.117
Journal volume & issue: Vol. 2, no. 3
pp. n/a – n/a

Abstract

No abstracts available.

Published in Clinical and Translational Discovery

ISSN: 2768-0622 (Online)
Publisher: Wiley
Country of publisher: Australia
LCC subjects: Medicine: Therapeutics. Pharmacology
Website: https://onlinelibrary.wiley.com/journal/27680622

About the journal